Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Rhythm · Phase 2 · Completed · Enrollment 164

NCT04963231

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Stage 1: Setmelanotide (Open-Label)75 participants41 participants22 participantsn/r0
Stage 2: Setmelanotide (Double-Blind)4 participants3 participants2 participantsn/r0
Stage 2: Placebo (Double-Blind)0 participants0 participants0 participantsn/r0

A count stays a count. This page does not turn a count into a percent.